Synthesis and antiangiogenic activity of new carbohydrate derivatives

Bioorganic and Medicinal Chemistry Letters

Volumn 6, Issue 24, 1996, Pages 3045-3050

  Dorey, G ^a   Leon P ^c   Sciberras, S ^a   Leonce S ^b   Guilbaud, N ^b   Pierre A ^b   Atassi, G ^b   Billington, D C ^d  

^a INSTITUT DE RECHERCHES SERVIER   (France)

^b INSTITUT DE RECHERCHES SERVIER   (France)

^c NONE   (France)

^d ASTON UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; EPOXIDE; FUMAGILLIN; FUMAGILLOL CHLOROACETYLCARBAMATE; OVALICIN; PYRAN DERIVATIVE; SPIRO COMPOUND; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; AORTA; ARTICLE; CARBOHYDRATE SYNTHESIS; CELL PROLIFERATION; CHICKEN; CHORIOALLANTOIS; CONTROLLED STUDY; DRUG STRUCTURE; HUMAN; HUMAN CELL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; STEREOCHEMISTRY; SWINE; TUMOR CELL;

EID: 0030591835     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(96)00564-1     Document Type: Article

References (33)

1. 2. a) Gonzalez-Crussi, F. Am. J. Anat., 1971, 130, 441.
2. b) Coffin, J.D.; Poole, T.J. Development, 1988,102, 735.
3. 3. For review see Findlay, J.K. J. Endocrinol., 1986, 111, 357.
4. 4. Madri, J.A.; Pratt, B.M. Clark R.A.F. and Henson P.M. (eds.). Plenum. New York. 1988, 337
5. 5. Davis, M.D.; Diabetes Metabol. Rev., 1988, 4, 291.
6. 6. a) Folkman, J. Sci. Am.., 1976, 234, 58.
7. b) Folkman, J.; Cotran, R. Int. Rev. Exp. Pathol., 1976, 16, 207.
8. c) Folkman, J. Adv. Cancer Res., 1985, 43, 175.
9. 7. a) Folkman, J. Ann. Surg., 1972, 175, 409.
10. b) Folkman, J. De Vita, V.T. Jr; Hellman, S.A.; Rosenberg, S.A. (eds.) Lippincott. Philadelphia, 1985, 42.
11. c) Folkman, J.; Engl. J. Med., 1989, 320, 1211.
12. 8. Ingber, D.; Fujita, T.; Kishimoto, S.; Sudo, K.; Kanamaru, T.; Brem, H.; Folkman, J. Nature, 1990, 348, 555.
13. 9. Levy, T. ; Kudelka, A. ; Verschraegen, C.F. ; Edwards, C.L. ; Freedman, R.S. ; Kaplan, A. ; Kieback, D. ; Steger, M. ; Mante, R. ; Gutterman, J. ; Piamsomboon, S. ; Termrungruanglert, W. ; Kavanagh, J.J. 87th Annual Meeting of the American Association for Cancer Research, Washington DC., April 20-24th, 1996, abst. N°1140.
14. 10. a) Sigg, H.P.; Weber, H.P. Helv. Chim. Acta., 1968, 51, 1395;
15. b) Bollinger, P.; Sigg, H.P.; Weber, H.P. Helv. Chim. Acta., 1973, 56, 819.
16. 11. a) Zimmerman, W.A.; Hartmann, G.R. Eur. J. Biochem., 1981, 118, 143;
17. b) Borel, J.F.; Lazary, S.; Staehelin, H. Agents and Actions, 1974, 4, 357.
18. 12. Corey, E.J. ; Dittami, J.P. J. Am. Chem. Sac., 1985, 107, 256.
19. 13. a) Corey, E.J.; Guzman-Perez, A.; Noe, M.C. J. Am. Chem. Soc., 1994, 116, 12109.
20. b) Bath, S.; Billington, D.C.; Géro, S.; Quiclet-Sire, B.; Samadi, M. J. Chem. Soc., Chem. Commun., 1994, 1495.
21. 14. Corey, E.J.; Snider, B. B. J. Am. Chem. Soc., 1972, 94, 2549.
22. 15. a) Marui, S. ; Itoh, F. ; Kozai, Y. ; Sudo, K. ; Kishimoto, S. Chem. Pharm. Bull., 1992, 40, 96 ;
23. b) Marui, S. ; Kishimoto, S. Chem. Pharm. Bull., 1992, 40, 575 ;
24. c) Marui, S. ; Yamamoto, T. ; Sudo, K. ; Akimoto, H. ; Kishimoto, S. Chem. Pharm. Bull., 1995, 43, 588.
25. 16. Campbell, M.M.; Heffernan, G.D. Tetrahedron Lett., 1991, 32, 1237.
26. 17. Brady, JR. R.F. Carbohydr. Res., 1970, 15, 35.
27. 18. Campbell, M.M.; Heffeman, G.D.; Lewis, T. Carbohydr. Res., 1994, 251, 243.
28. 19. Nashed, M.A.; Anderson, L. Tetrahedron Lett., 1976, 3503.
29. 20. Evaluation of the percentage of eggs with an avascular zone, allows the identification of specific antiangiogenic derivatives devoid of toxicity. Compounds showing local hemorrhage, marked distorsion of large preexisting vessels and/or death of the embryo were not selected as potential antiangiogenic drugs.
30. 21. Crum, R.; Szabo, S.; Folkman, J. Science, 1985, 230, 1375.
31. 22. For related methodology see Pierré, A. ; Kraus-Berthier, L. ; Atassi, G. ; Cros, S. ; Poupon, M-F. ; Lavielle, G. ; Berlion, M. ; Bizzari, J-P. Cancer Res., 1991, 51, 2312.
32. 23 Kusaka, M. ; Sudo, K. ; Matsutani, E. ; Kozai, Y. ; Marui, S. ; Fujita, T. ; Ingber, D. ; Folkman, J. Br. J. Cancer, 1994, 69, 212
33. 13C NMR, mass spectral, and elemental analysis data, in full agreement with their assigned structures and stereochemistries. Experimental procedures and analytical data have been published elsewhere ; Adir and Co ; European Patent, 0699679 (EP 0699679), p. 96-130711/14, 1996.